ATW SPAC MANAGEMENT LLC - CARDIO DIAGNOSTICS HOLDGS IN ownership

CARDIO DIAGNOSTICS HOLDGS IN's ticker is and the CUSIP is 14159C111. A total of 17 filers reported holding CARDIO DIAGNOSTICS HOLDGS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ATW SPAC MANAGEMENT LLC ownership history of CARDIO DIAGNOSTICS HOLDGS IN
ValueSharesWeighting
Q2 2024$2,355
-63.4%
60,5400.0%0.00%
-62.5%
Q1 2024$6,441
-38.8%
60,5400.0%0.01%
-46.7%
Q4 2023$10,528
+323.7%
60,5400.0%0.02%
+275.0%
Q3 2023$2,485
-78.2%
60,5400.0%0.00%
-50.0%
Q2 2023$11,412
-41.1%
60,5400.0%0.01%
+33.3%
Q1 2023$19,367
+291.3%
60,540
-39.5%
0.01%
+500.0%
Q4 2022$4,950100,0000.00%
Other shareholders
CARDIO DIAGNOSTICS HOLDGS IN shareholders Q1 2023
NameSharesValueWeighting ↓
ATW SPAC MANAGEMENT LLC 60,540$2,3550.00%
BOOTHBAY FUND MANAGEMENT, LLC 60,540$33,2970.00%
Context Capital Management, LLC 81,500$3,1700.00%
Walleye Trading LLC 132,265$5,1450.00%
HRT FINANCIAL LP 36,000$10.00%
Saba Capital Management, L.P. 199,839$7,1840.00%
CLEAR STREET LLC 83,042$30.00%
D. E. Shaw & Co., Inc. 74,822$2,9930.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 10,001$3900.00%
View complete list of CARDIO DIAGNOSTICS HOLDGS IN shareholders